Effect of Hormone Therapy on Muscle Mass in Postmenopausal Women
Although use of hormone therapy can have some protective effect on muscle mass in postmenopausal women, the benefit is small in the general population.
Hormone Replacement Therapy
Type and Timing of Menopausal Hormone Therapy May Affect Breast Cancer Risk
Use of menopausal hormonal therapy for 5 years around the start of menopause may be associated with increased risk for breast cancer.
Hormone Replacement Therapy May Increase Risk for Alzheimer Disease
Long-term use of systemic hormone replacement therapy may slightly increase the risk of developing Alzheimer disease.
Hormone Therapy May Affect Cardiovascular Profiles in Transgender Persons
Investigators evaluated whether treatment with one year of oral or transdermal administration of estrogen plus cyproterone and transdermal or intramuscular application of testosterone caused changes in serum lipids and blood pressure.
Hormone Therapy Linked to Reduced Symptomatic Knee OA in Postmenopausal Women
Hormone therapy in postmenopausal women may be protective against knee OA.
Impact of Women’s Health Initiative on Menopausal Hormone Therapy Trends
Initiation and continuation trends in menopausal hormone therapy may have been influenced by the premature cessation of the 2002 Women’s Health Initiative trial, which was halted due to safety concerns.
Tissue-Selective Estrogen Complex May Benefit Postmenopausal Women With Vaginal Bleeding, Breast Discomfort
Switching to tissue-selective estrogen complex from hormone therapy may benefit women with breast discomfort or vaginal bleeding.
Hormone Therapy Not Beneficial in Subclinical Hypothyroidism
No benefit regarding quality of life or thyroid-related symptoms found for thyroid hormone therapy.
Bacterial vaginosis may alter links between contraception, HIV acquisition
Bacterial vaginosis may cause an increased risk for HIV acquisition in women taking oral or injectable hormonal contraception.
Menopausal hormone therapy for chronic conditions: USPSTF’s final recommendation
The USPSTF has updated its recommendations on the use of menopausal hormone therapy for the primary prevention of chronic conditions.
